5. Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average shares of common stock outstanding. For purposes of calculating diluted earnings (loss) per share, the denominator includes both the weighted average shares of common stock outstanding and dilutive common stock equivalents. Dilutive common stock equivalents consist of stock options, restricted stock unit awards and warrants calculated under the treasury stock method.

The calculations of earnings (loss) per share are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(In thousands, except per share amounts)	2017			2016			2017			2016
Basic Loss per Common Share:
Net loss	$	(143,011	)	$	(2,136	)	$	(151,576	)	$	(9	)
Less: Net loss (income) attributable to non-controlling interests		264			87			(189	)		9
Less: Accretion of redemption preference on redeemable convertible non-controlling interest - Netsmart		(10,963	)		(8,153	)		(21,925	)		(8,153	)
Net loss attributable to Allscripts Healthcare Solutions, Inc. stockholders	$	(153,710	)	$	(10,202	)	$	(173,690	)	$	(8,153	)

Weighted-average common shares outstanding		181,193			186,792			180,981			187,676

Basic Loss per Common Share	$	(0.85	)	$	(0.05	)	$	(0.96	)	$	(0.04	)

Diluted Loss per Common Share:
Net loss	$	(143,011	)	$	(2,136	)	$	(151,576	)	$	(9	)
Less: Net loss (income) attributable to non-controlling interests		264			87			(189	)		9
Less: Accretion of redemption preference on redeemable convertible non-controlling interest - Netsmart		(10,963	)		(8,153	)		(21,925	)		(8,153	)
Net loss attributable to Allscripts Healthcare Solutions, Inc. stockholders	$	(153,710	)	$	(10,202	)	$	(173,690	)	$	(8,153	)

Weighted-average common shares outstanding		181,193			186,792			180,981			187,676
Plus: Dilutive effect of stock options, restricted stock unit awards and warrants		0			0			0			0
Weighted-average common shares outstanding assuming dilution		181,193			186,792			180,981			187,676

Diluted Loss per Common Share	$	(0.85	)	$	(0.05	)	$	(0.96	)	$	(0.04	)

As a result of the net loss attributable to Allscripts Healthcare Solutions, Inc. stockholders for the three and six months ended June 30, 2017 and 2016, we used basic weighted-average common shares outstanding in the calculation of diluted loss per share for that period, since the inclusion of any stock equivalents would be anti-dilutive.

The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:

Three Months Ended

June 30,

Six Months Ended

June 30,

(In thousands)

2017

2016

2017

2016

Shares subject to anti-dilutive stock options, restricted stock

unit awards and warrants excluded from calculation

26,652

25,210

26,668

25,227